3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Head and Neck Neoplasms
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Gastric Adenocarcinoma
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
9
Nivolumab
8
pembrolizumab
7
fludarabine phosphate
7
fludarabine
6
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
Cyclosporine
5
Brentuximab Vedotin
5
Melphalan
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Specimen Handling
3
Etoposide
3
Thiotepa
2
Sirolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.